Skip to main content
Veterinary Medicines

RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS

Authorised
  • Cephalexin benzathine

Product identification

Medicine name:
RILEXINE DC 375 MG INTRAMAMMARY SUSPENSION FOR DRY COWS
Rilexine DC, 375 mg, intramaminė suspensija užtrūkusioms karvėms
Active substance:
  • Cephalexin benzathine
Target species:
  • Cattle (dry cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cephalexin benzathine
    500.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dry cow)
      • Meat and offal
        4
        day
      • Milk
        43
        day
      • Milk
        12
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DB01
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:
  • Box of 12 x 8g intramammary syringes and 12 cleaning towels
  • Box of 60 x 8g intramammary syringes and 60 cleaning towels
  • Box of 24 x 8g intramammary syringes and 24 cleaning towels

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
  • Virbac
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/22/2703/001-003
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0438/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

RV2703.pdf

Lithuanian (PDF)
Published on: 29/07/2025
Download